{"id":487,"date":"2022-06-21T20:22:14","date_gmt":"2022-06-21T13:22:14","guid":{"rendered":"https:\/\/iado.id\/h\/?page_id=487"},"modified":"2026-03-11T17:26:21","modified_gmt":"2026-03-11T10:26:21","slug":"penyelesaian-publik","status":"publish","type":"page","link":"https:\/\/iado.id\/h\/index.php\/id\/penyelesaian-publik\/","title":{"rendered":"Penyelesaian Publik"},"content":{"rendered":"\n

Penyelesaian Kasus Anti-Doping<\/h2>\n\n\n\n
Nama<\/th>Kebangsaan<\/th>Sports<\/th>Zat\/Alasan<\/th>Jenis Pelanggaran Anti-Doping<\/strong><\/th>Periode Ban<\/th>Periode Larangan Keikutsertaan<\/strong><\/th><\/tr><\/thead>
Hismawan Sulistiono<\/td>INA<\/td>Bodybuilding<\/td>S1. stanozolol, S1. drostanolone<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>18 Desember 2024 s.d. 17 Desember 2028<\/td><\/tr>
Dody Armanda Putra<\/td>INA<\/td>Bodybuilding<\/td>S1. stanozolol, S1. drostanolone, S1. fluoxymesterone, S1. clenbuterol<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>18 Desember 2024 s.d. 17 Desember 2028<\/td><\/tr>
Agung Wibowo<\/td>INA<\/td>Bodybuilding<\/td>S1. drostanolone, S1. stanozolol<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>18 Desember 2024 s.d. 17 Desember 2028<\/td><\/tr>
Indra Mulyadi<\/td>INA<\/td>Bodybuilding<\/td>S1. boldenone<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>18 Desember 2024 s.d. 17 Desember 2028<\/td><\/tr>
Wawan Bayu Riswana<\/td>INA<\/td>Bodybuilding<\/td>S1. metenolone, S1. drostanolone, S1. mestanolone, S1. stanozolol<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>18 Desember 2024 s.d. 17 Desember 2028<\/td><\/tr>
Achmad Alvian<\/td>INA<\/td>Bodybuilding<\/td>S6. amfetamine, S6. methamfetamine (D-)<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>22 November 2024 s.d. 21 November 2028<\/td><\/tr>
Muhammad Ibnul Rizqih<\/td>INA<\/td>Weightlifting<\/td>Furosemide<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>10 Januari 2025 s.d. 9 Januari 2029<\/td><\/tr>
Stephen Mungathia Mugambi<\/td>KEN<\/td>Athletics<\/td>19-norandrosterone, 19-noretiocholanolone<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>6 September 2024 s.d. 5 September 2028<\/td><\/tr>
Odie Purnama Setiawan<\/td>INA<\/td>Cycling<\/td>stanozolol metabolites 3′-hydroxy-stanozolol, 4\u03b2-hydroxystanozolol, 16\u03b2-hydroxy-stanozolol<\/td>2.1 Keberadaan Zat Terlarang<\/td>3 (tiga) tahun<\/td>16 April 2024 s.d. 15 April 2027<\/td><\/tr>
Willi Ramadhita<\/td>INA<\/td>Bodybuilding<\/td>Stanozolol metabolit, GW1516 metabolit<\/td>2.1 Keberadaan Zat Terlarang<\/td>3 (tiga) tahun<\/td>19 Januari 2024 s.d. 18 Januari 2027<\/td><\/tr>
Agung Budi Laksono<\/td>INA<\/td>Bodybuilding<\/td>Stanozolol, Drostanolone, Clenbuterol<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>17 Juli 2023 s.d. 16 Juli 2027<\/td><\/tr>
Benny Michael Kaunang<\/td>INA<\/td>Bodybuilding<\/td>Stanozolol<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>17 Juli 2023 s.d. 16 Juli 2027<\/td><\/tr>
Misnadi<\/td>INA<\/td>Bodybuilding<\/td>Stanozolol, Drostanolone, Clenbuterol<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>17 Juli 2023 s.d. 16 Juli 2027<\/td><\/tr>
Glenn Victor Susanto<\/td>INA<\/td>Swimming<\/td>Octodrine (1,5-dimethyl-hexylamine)<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>26 April 2023 s.d. 25 April 2027<\/td><\/tr>
Roy Joedie<\/td>INA<\/td>Bodybuilding<\/td>Non-Analisis\/Penolakan (ADRV 2.3 pada World Anti-Doping Code 2021)<\/td>2.3 Penghindaran, Penolakan, atau Kegagalan Untuk Menyampaikan Kumpulan Sampel<\/td>4 (empat) tahun<\/td>9 Februari 2023 s.d. 8 Februari 2027<\/td><\/tr>
Tjhie Rahmat Wijaya<\/td>INA<\/td>Bodybuilding<\/td>Hydrochlorothiazide <\/td>2.1 Keberadaan Zat Terlarang<\/td>2 (dua) tahun<\/td>7 November 2023 s.d. 6 November 2025<\/td><\/tr>
Carel Julius*<\/td>INA<\/td>Weightlifting<\/td>Trenbolone<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>24 Desember 2021 s.d. 23 Desember 2025<\/td><\/tr>
Putu Martika*<\/td>INA<\/td>Bodybuilding<\/td>SARMS LGD-4033 (ligandrol)<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>18 Februari 2022 s.d. 17 Februari 2026<\/td><\/tr>
Abdul Manan*<\/td>INA<\/td>Bodybuilding<\/td>Drostanolone, Stanozolol, Trenbolone<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>24 Desember 2021 s.d. 23 Desember 2025<\/td><\/tr>
Putri Aulia Andriani*<\/td>INA<\/td>Weightlifting<\/td>Metadienone<\/td>2.1 Keberadaan Zat Terlarang<\/td>3 (tiga) tahun<\/td>18 Februari 2022 s.d. 17 Februari 2025<\/td><\/tr>
Laura Aurelia Dinda Sekar Devanti*<\/td>INA<\/td>Para Swimming<\/td>Sibutramine<\/td>2.1 Keberadaan Zat Terlarang<\/td>2 (dua) tahun<\/td>18 Februari 2022 s.d. 17 Februari 2024<\/td><\/tr>
Kariyono*<\/td>INA<\/td>Bodybuilding<\/td>Drostanolone, Metenolone<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>24 Desember 2021 s.d. 23 Desember 2025<\/td><\/tr>
Andri Yanto*<\/td>INA<\/td>Bodybuilding<\/td>Drostanolone, Metenolone<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>24 Desember 2021 s.d. 23 Desember 2025<\/td><\/tr>
Agus Purnomo*<\/td>INA<\/td>Bodybuilding<\/td>SARMS LGD-4033 (ligandrol)<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>24 Desember 2021 s.d. 23 Desember 2025<\/td><\/tr>
Warochim*<\/td>INA<\/td>Bodybuilding<\/td>Stanozolol, Trenbolone, Drostanolone, Metenolone<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>24 Desember 2021 s.d. 23 Desember 2025<\/td><\/tr>
Alvin Tehupeiory*<\/td>INA<\/td>Atletik<\/td>Hydrochlorothiazide<\/td>2.1 Keberadaan Zat Terlarang<\/td>6 (enam) bulan<\/td>21 September 2021 s.d. 21 Maret 2022<\/td><\/tr>
Mariska Halinda*<\/td>INA<\/td>Taekwondo<\/td>Furosemide<\/td>2.1 Keberadaan Zat Terlarang<\/td>4 (empat) tahun<\/td>8 Juli 2020 s.d. 7 Juli 2024<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Note:
*) Yang bersangkutan telah selesai menjalakan periode larangan keikutsertaan.<\/p>\n","protected":false},"excerpt":{"rendered":"

Penyelesaian Kasus Anti-Doping Nama Kebangsaan Sports Zat\/Alasan Jenis Pelanggaran Anti-Doping Periode Ban Periode Larangan Keikutsertaan Hismawan Sulistiono INA Bodybuilding S1. stanozolol, S1. drostanolone 2.1 Keberadaan Zat Terlarang 4 (empat) tahun 18 Desember 2024 s.d. 17 Desember 2028 Dody Armanda Putra INA Bodybuilding S1. stanozolol, S1. drostanolone, S1. fluoxymesterone, S1. clenbuterol 2.1 Keberadaan Zat Terlarang 4 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"class_list":["post-487","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/iado.id\/h\/index.php\/wp-json\/wp\/v2\/pages\/487","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/iado.id\/h\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/iado.id\/h\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/iado.id\/h\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/iado.id\/h\/index.php\/wp-json\/wp\/v2\/comments?post=487"}],"version-history":[{"count":14,"href":"https:\/\/iado.id\/h\/index.php\/wp-json\/wp\/v2\/pages\/487\/revisions"}],"predecessor-version":[{"id":6700,"href":"https:\/\/iado.id\/h\/index.php\/wp-json\/wp\/v2\/pages\/487\/revisions\/6700"}],"wp:attachment":[{"href":"https:\/\/iado.id\/h\/index.php\/wp-json\/wp\/v2\/media?parent=487"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}